CN116997662A - 传染病检查方法 - Google Patents

传染病检查方法 Download PDF

Info

Publication number
CN116997662A
CN116997662A CN202180095879.0A CN202180095879A CN116997662A CN 116997662 A CN116997662 A CN 116997662A CN 202180095879 A CN202180095879 A CN 202180095879A CN 116997662 A CN116997662 A CN 116997662A
Authority
CN
China
Prior art keywords
facility
sample
collection
information
infectious
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180095879.0A
Other languages
English (en)
Chinese (zh)
Inventor
八十岛诚
岳盛公昭
醍醐福米
友野卓哉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shimadzu Corp
Original Assignee
Shimadzu Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shimadzu Corp filed Critical Shimadzu Corp
Publication of CN116997662A publication Critical patent/CN116997662A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/02—Devices for withdrawing samples
    • G01N1/10—Devices for withdrawing samples in the liquid or fluent state
    • G01N1/20—Devices for withdrawing samples in the liquid or fluent state for flowing or falling materials
    • G01N1/2035—Devices for withdrawing samples in the liquid or fluent state for flowing or falling materials by deviating part of a fluid stream, e.g. by drawing-off or tapping
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C12M1/26—Inoculator or sampler
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/80—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for detecting, monitoring or modelling epidemics or pandemics, e.g. flu
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Sustainable Development (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hydrology & Water Resources (AREA)
  • Data Mining & Analysis (AREA)
  • Toxicology (AREA)
  • Databases & Information Systems (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
CN202180095879.0A 2021-03-25 2021-06-18 传染病检查方法 Pending CN116997662A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021052117 2021-03-25
JP2021-052117 2021-03-25
PCT/JP2021/023270 WO2022201567A1 (ja) 2021-03-25 2021-06-18 感染症検査方法

Publications (1)

Publication Number Publication Date
CN116997662A true CN116997662A (zh) 2023-11-03

Family

ID=82849858

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180095879.0A Pending CN116997662A (zh) 2021-03-25 2021-06-18 传染病检查方法

Country Status (6)

Country Link
US (1) US20240142350A1 (enExample)
EP (1) EP4317395A4 (enExample)
JP (4) JP7031957B1 (enExample)
CN (1) CN116997662A (enExample)
AU (1) AU2021436402B2 (enExample)
WO (1) WO2022201567A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023210597A1 (ja) * 2022-04-25 2023-11-02 株式会社島津テクノリサーチ 試料採取装置
JPWO2024185253A1 (enExample) * 2023-03-08 2024-09-12

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11256543A (ja) * 1998-03-13 1999-09-21 Hitachi Ltd 感染症病原リスク管理マッピングシステム
US20110266454A1 (en) * 2009-09-15 2011-11-03 Mirion Technologies (Rados) Gmbh Method for Detecting Contamination on a Moving Object
CN111444279A (zh) * 2020-04-03 2020-07-24 长春市万易科技有限公司 一种基于区块链的人员流动记录系统及方法
US20200385296A1 (en) * 2019-06-04 2020-12-10 Biobot Analytics, Inc. Method for characterizing the prevalence of a biochemical condition within a population

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5319543A (en) * 1992-06-19 1994-06-07 First Data Health Services Corporation Workflow server for medical records imaging and tracking system
US7399447B2 (en) 2004-04-01 2008-07-15 Enigma Science, Llc Active sampler for detecting contaminants in liquids
CN201395237Y (zh) 2009-03-27 2010-02-03 北京师范大学 应用于突发性污染河流应急处理的竹排式吸附筏
JP5636685B2 (ja) * 2010-02-02 2014-12-10 独立行政法人水産総合研究センター ノロウイルス検出用材料および該材料を用いるノロウイルスの検出方法
CN202297198U (zh) 2011-09-30 2012-07-04 北京师范大学 对溢油污染海水具有吸附功能的可生物降解浮床
JP2015143924A (ja) * 2014-01-31 2015-08-06 ケーディーアイコンズ株式会社 情報処理装置及びプログラム
EP3570315B1 (en) * 2015-03-06 2024-01-31 Micromass UK Limited Rapid evaporative ionisation mass spectrometry ("reims") and desorption electrospray ionisation mass spectrometry ("desi-ms") analysis of biopsy samples

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11256543A (ja) * 1998-03-13 1999-09-21 Hitachi Ltd 感染症病原リスク管理マッピングシステム
US20110266454A1 (en) * 2009-09-15 2011-11-03 Mirion Technologies (Rados) Gmbh Method for Detecting Contamination on a Moving Object
US20200385296A1 (en) * 2019-06-04 2020-12-10 Biobot Analytics, Inc. Method for characterizing the prevalence of a biochemical condition within a population
CN111444279A (zh) * 2020-04-03 2020-07-24 长春市万易科技有限公司 一种基于区块链的人员流动记录系统及方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MOHAMED HAMOUDA ET AL: ""Wastewater surveillance for SARS-CoV-2: Lessons learnt from recent studies to define future applications", 《SCI TOTAL ENVIRON》, 7 November 2020 (2020-11-07), pages 1 - 20 *

Also Published As

Publication number Publication date
US20240142350A1 (en) 2024-05-02
JP7582272B2 (ja) 2024-11-13
JP2025016645A (ja) 2025-02-04
AU2021436402B2 (en) 2025-06-26
WO2022201567A1 (ja) 2022-09-29
JP2022151884A (ja) 2022-10-07
AU2021436402A1 (en) 2023-10-12
JP7118370B1 (ja) 2022-08-16
JP7031957B1 (ja) 2022-03-08
JP2022151641A (ja) 2022-10-07
JPWO2022201567A1 (enExample) 2022-09-29
EP4317395A1 (en) 2024-02-07
EP4317395A4 (en) 2024-09-11

Similar Documents

Publication Publication Date Title
Keshaviah et al. Developing a flexible national wastewater surveillance system for COVID-19 and beyond
World Health Organization Environmental surveillance for SARS-CoV-2 to complement other public health surveillance
Hantrakun et al. Clinical epidemiology of 7126 melioidosis patients in Thailand and the implications for a national notifiable diseases surveillance system
Hrudey et al. The devil is in the details: emerging insights on the relevance of wastewater surveillance for SARS-CoV-2 to public health
JP2025016645A (ja) 感染症検査方法
World Health Organization Environmental surveillance for SARS-COV-2 to complement public health surveillance: interim guidance, 14 April 2022
Shah et al. A Canadian screening program for hepatitis C: Is now the time?
Scassa et al. The Datafication of Wastewater:: Legal, Ethical and Civic Considerations
Honda et al. Public health benefits and ethical aspects in the collection and open sharing of wastewater-based epidemic data on COVID-19
Joung et al. Coupling wastewater-based epidemiological surveillance and modelling of SARS-COV-2/COVID-19: practical applications at the Public Health Agency of Canada
Eaton et al. A framework for public health authorities to evaluate health determinants for wastewater-based epidemiology
Neyra et al. Establishing a statewide wastewater surveillance system in response to the COVID-19 pandemic: a reliable model for continuous and emerging public health threats
World Health Organization Diagnostic test for surveillance of lymphatic filariasis: target product profile
Keck et al. Wastewater surveillance for SARS-CoV-2 at long-term care facilities: mixed methods evaluation
Kim et al. Wastewater monitoring of SARS-CoV-2 RNA at K-12 schools: comparison to pooled clinical testing data
Maal-Bared et al. To sample or not to sample: A governance-focused decision tree for wastewater service providers considering participation in wastewater-based epidemiology (WBE) in support of public health programs
Rector et al. Detection of measles virus genotype D8 in wastewater of the Brussels capital region, Belgium
Rainey et al. Assessment of a mass balance equation for estimating community-level prevalence of COVID-19 using wastewater-based epidemiology in a mid-sized city
Bayraktar et al. How to diagnose COVID-19 in family practice? Usability of complete blood count as a COVID-19 diagnostic tool: a cross-sectional study in Turkey
World Health Organization Surveillance template protocol for pfhrp2/pfhrp3 gene deletions
Gleason et al. Development and evaluation of statewide prospective spatiotemporal legionellosis cluster surveillance, New Jersey, USA
Prakash Increasing trends in unhealthy practices of clinical laboratory medicine service in Nepal
Murphree et al. La Crosse encephalitis surveillance using single versus paired serologic testing
Knutsson From end-use characterization to decentralized reuse design: closing the data-to-system gap
Nikiforuk et al. Implementing wastewater surveillance for viral pathogens: lessons learned from SARS-CoV-2, monkeypox virus, norovirus and influenza A viruses

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination